Attached files
| file | filename |
|---|---|
| 10-Q - Emergent BioSolutions Inc. | form10-q063016.htm |
| EX-10.3 - Emergent BioSolutions Inc. | ex10_3.htm |
| EX-10.2 - Emergent BioSolutions Inc. | ex10_2.htm |
| EX-3 - Emergent BioSolutions Inc. | ex3.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_1.htm |
| EX-12 - Emergent BioSolutions Inc. | ex12.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Emergent BioSolutions Inc. (the "Company") for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Daniel Abdun-Nabi, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: August 5, 2016
/s/DANIEL J. ABDUN-NABI
Daniel J. Abdun-Nabi
Chief Executive Officer